Teaming with Jeff Lowenfels
Lord of the Roots, Best selling Author, Organic Cannabis Advocate. Attorney
Dr. Pritesh Kumar is Head of Capital Markets at Achio Capital Partners. Dr. Kumar is a highly regarded scientist and entrepreneur with a deep understanding of the legal cannabis industry, including biotechnology and pharmaceuticals. Dr. Kumar was the founder and Managing Director of PhytoSciences GmbH, a Swiss-based consulting firm comprised of 100+ scientists & analysts across the EU, India, Canada, Africa, and USA. The firm advised stakeholders in the areas of investment due diligence, analytical testing, clinical trial solutions, novel drug delivery technology development, and commercial bioprocessing. Under his direction, the firm assisted start-up companies raise over $150M USD in equity & debt financing.
His professional working experience includes working in the academic, private and public sectors. He has held senior roles for several cannabis companies in Canada and Europe that have experienced both public and private exits. Dr. Kumar previously served as the CSO for PharmaCielo Ltd (TSXV: PCLO) (OTCQX: PCLOF), a Canadian company with operations in Colombia, South America. He was responsible for the company’s R&D, global business product development strategy, and Phase I development of a state- of-the-art GMP pharmaceutical cannabis bioprocessing plant. Dr. Kumar previously served as an Advisor to the WHO (World Health Organization) based in Geneva, Switzerland. In this role, Dr. Kumar provided consultation services to the 40th Meeting of the Expert Committee on Drug Dependence regarding Cannabis Toxicology.
His academic working experience includes serving as the Director of Cannabinoid Research at Canadore College in Canada. Previously, Dr. Kumar was Adjunct Faculty & Scientific Advisor for Addis Ababa University, School of Pharmacy (SoP) in Ethiopia. Dr. Kumar has been published in numerous scientific journals including the European Journal of Pharmacology, Pharmacology and Physiology, Journal of Medicinal Chemistry, Investigative Ophthalmology & Visual Science and Biochemical and Biophysical Research Communications, and Advances in Skin and Wound Care.
He holds both a Master of Science and Ph.D. in Pharmacology and Toxicology, with a focus in cannabinoid (cannabis) pharmacology, from the University of Louisville, Kentucky USA. Previously, Dr. Kumar conducted pharmacological testing of FDA- approved drugs as potential ligands for the cannabinoid receptor 2 (CB2) and investigated the pharmacology of cannabinoids.